Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: 10q

Your point is valid and well taken. Although, I sumbit to you that with info from PTSC being scarse, shareholders need to glean as much as possible from PR's, Q's and Pacers. Albiet 1/10 of 1% is not inordinately a big deal, taken collectively w/previous and future buybacks, it could have a positive impact on both preception and the bottom line. I remain optimistic. all imho kw

Share
New Message
Please login to post a reply